Log in

317450 Myung in Pharm Co., Ltd. KRX · South Korea

Myung in Pharm Co. (317450) news

Myung in Pharm Co., Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 317450, recorded under South Korea. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Myung in Pharm Co. news

We have not published a story on Myung in Pharm Co. yet. When there is news, it will appear here.

Questions about Myung in Pharm Co.

What is the ticker symbol of Myung in Pharm Co.?

Myung in Pharm Co., Ltd. trades under the ticker 317450 on KRX.

Where is Myung in Pharm Co. listed?

Myung in Pharm Co., Ltd. is listed on KRX.

Which country or territory is Myung in Pharm Co. listed under?

Our directory records Myung in Pharm Co., Ltd. under South Korea.

What does Myung in Pharm Co. do?

Our directory classifies Myung in Pharm Co., Ltd. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Myung in Pharm Co.?

The ISIN recorded for Myung in Pharm Co., Ltd. is KR7317450005.

Does aibio.space cover Myung in Pharm Co.?

aibio.space lists Myung in Pharm Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Myung in Pharm Co.?

Companies in our directory listed in the same country and business area as Myung in Pharm Co.: Handok, FutureChem Co., Kwang Dong Pharmaceutical Co., ChoA Pharmaceutical Co., PHARMARESEARCH BIO Co., HL GENOMICS Co..

Investor discussion: Myung in Pharm Co.

Members talk about Myung in Pharm Co. (317450). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:317450 on TradingView.

Listing details

Myung in Pharm Co., Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 317450, recorded under South Korea. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Myung in Pharm Co., Ltd.
Ticker
317450
Listing
KRX
Country or territory
South Korea
Business scope
Biopharma / pharmaceutical profile checked
ISIN
KR7317450005
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.